ReviewApplied microscopy2026
Cationic lipid-based nanoparticles for therapeutic delivery in cancer treatment: physicochemical characteristics, therapeutic cargos, and clinical potential.
Review in Applied microscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Leciplex Nanocarriers: An Optimized Platform for Thymol Delivery in Acne Management.Pharmaceutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past few decades, numerous biological therapeutics, such as RNAs and polypeptides, have emerged as promising alternatives to traditional chemotherapy. While their molecular mechanisms of action are well-understood, their clinical application remains hindered by several critical barriers, including inherent intracellular instability, the need for precise target-site delivery, poor cellular uptake, and immune system clearance. To overcome these challenges, the development of selective delivery systems has been raised as an indispensable strategy. Among various drug carriers, cationic lipid-based platforms have garnered significant attention and are increasingly exploited in oncology. This review summarizes the physicochemical characteristics of cationic lipid-based nanoparticles and evaluates various therapeutic cargos based on their biological properties. Furthermore, we explore the current research applications and clinical potential of these nanoparticles in cancer treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.